Price competition in pharmaceuticals: The case of anti-infectives

Economic Inquiry

Volumn 42, Issue 2, 2004, Pages 247-263

  Wiggins, Steven N ^a   Maness, Robert ^b  

^a TEXAS A AND M UNIVERSITY   (United States)

^b Law and Economics Consulting Group   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 2442529778     PISSN: 00952583     EISSN: None     Source Type: Journal    
DOI: 10.1093/ei/cbh058     Document Type: Article

References (29)

1. Applebaum, E. "The Estimation of the Degree of Oligopoly Power." Journal of Econometrics, 19, 1982, 287-99.
2. Bresnahan, T. F. "Departures from Marginal-Cost Pricing in the American Automobile Industry: Estimates for 1977-1978." Journal of Econometrics, 11, 1981, 201-27.
3. -. "Empirical Studies of Industries with Market Power," in The Handbook of Industrial Organization, edited by R. Schmalensee and R. Willig. North-Holland, Amsterdam, 1989.
4. Bresnahan, T. F., and P. C. Reiss. "Entry and Competition in Concentrated Markets." Journal of Political Economy, 99(5), 1991, 977-1009.
5. Caves, Richard E., Michael D. Whinston, and Mark A. Hurwitz. "Patent Expiration, Entry and Competition in the U.S. Pharmaceutical Industry." Brookings Papers on Economic Activity: Microeconomics, 1991, 1-66.
6. Congressional Budget Office. How Increased Competition from Generic Drugs Has Affected Prices and Returns in the Pharmaceutical Industry. July 1998.
7. Dunne, Timothy, and Mark J. Roberts. "Costs, Demand, and Imperfect Competition as Determinants of Plant-Level Output Prices." Manuscript, Department of Economics, Pennsylvania State University, December 1991.
8. Ellison, Sara F. "What Prices Can Tell Us about the Market for Antibiotics." Working Paper, MIT, July 1998.
9. Ellison, Sara F., Iain Cockburn, Zvi Griliches, and Jerry Hausman. "Characteristics of the Demand for Pharmaceutical: An Examination of Four Cephalosporins." Rand Journal of Economics, 28(3), 1997, 426-46.
10. Frank, Richard G., and David S. Salkever. "Pricing, Patent Loss and the Market for Pharmaceuticals." Southern Economic Journal, October 1992, 165-79.
11. -. "Generic Entry and the Pricing of Pharmaceuticals." Journal of Economics & Management Strategy, 6(1), 1997, 75-90.
12. Grabowski, Henry G., and John M. Vernon. "Brand Loyalty, Entry and Price Competition in Pharmaceuticals after the 1984 Drug Act." Journal of Law & Economics, 35, October 1992, 331-50.
13. -. "Longer Patents for Increased Generic Competition: The Waxman-Hatch Act after One Decade." PharmacoEconomics, 10(suppl 2), 1996, 110-23.
14. Greene, William H. Econometric Analysis, 2nd ed. New York: Macmillan, 1993.
15. Griliches, Zvi, and Iain Cockburn. "Generics and New Goods in Pharmaceutical Price Indexes." American Economic Review, 84(5), 1994, 1213-32.
16. Lichtenberg, Frank R. "Are the Benefits of Newer Drugs Worth Their Cost? Evidence from the 1996 MEPS." Health Affairs, September/October 2001, 241-51.
17. Lu, Z. John, and William Comanor. "Strategic Pricing of New Pharmaceuticals." Review of Economics and Statistics, 80, February 1998, 108-18.
18. Masson, Alison, and Robert L. Steiner. Generic Substitution and Prescription Drug Prices: Economic Effects of State Product Selection Laws. Washington, DC: Federal Trade Commission, 1985.
19. Porter, R. "A Study of Cartel Stability: The Joint Executive Committee, 1880-1886." Bell Journal of Economics, 14, 1983, 301-14.
20. Reiffen, David, and Michael R. Ward. "Generic Drug Industry Dynamics." Working Paper, FTC, February 2002.
21. Reiss, Peter C., and Pablo T. Spiller. "Competition and Entry in Small Airline Markets." Journal of Law & Economics, 32, October 1989, S179-S202.
22. Schmalensee, Richard. "Entry Deterrence in the Ready-to-Eat Breakfast Cereal Industry." Bell Journal of Economics, 1978, 305-27.
23. Schwartzman, David. Innovation in the Pharmaceutical Industry. Baltimore, MD: Johns Hopkins University Press, 1976.
24. Scientific American Medicine. Edited by Edward Rubinstein and Daniel Federman. New York: Scientific American, 1994.
25. Scott Morton, Fiona M. "Entry Decisions in the Generic Pharmaceutical Industry." Rand Journal of Economics, 30(3), Autumn 1999, 421-40.
26. Scott Morton, Fiona M. "Barriers to Entry, Brand Advertising, and Generic Entry in the US Pharmaceutical Industry." International Journal of Industrial Organization, 18, 2000, 1085-104.
27. Stern, Scott. "Product Demand in Pharmaceutical Markets." Mimeo, Sloan School of Management, MIT, 1994.
28. Suslow, V. "Estimating Monopoly Behavior with Competitive Recycling: An Application to Alcoa." Rand Journal of Economics, 17(3), 1986, 389-403.
29. Wiggins, Steven N., and Robert Maness. "Price Competition in Pharmaceutical Markets: The Case of Anti-infectives." Working Paper, Texas A&M University, 1998.